(19)
(11) EP 2 666 415 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
11.08.2021 Bulletin 2021/32

(45) Mention of the grant of the patent:
23.06.2021 Bulletin 2021/25

(21) Application number: 13169004.2

(22) Date of filing: 23.05.2013
(51) International Patent Classification (IPC): 
A61B 8/12(2006.01)
A61M 25/10(2013.01)
A61B 5/00(2006.01)
A61M 25/00(2006.01)
 A61B 8/00(2006.01)
A61B 18/00(2006.01)
A61B 10/02(2006.01)
A61B 10/04(2006.01)

(54)

Endobronchial catheter

Endobronchialer Katheter

Cathéter endobronchique

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 23.05.2012 US 201261650615 P
09.05.2013 US 201313890294

(43) Date of publication of application:
27.11.2013 Bulletin 2013/48

(60) Divisional application:
21180913.2
21180971.0

(73) Proprietor: Biosense Webster (Israel), Ltd.
20692 Yokneam (IL)

(72) Inventors:
  • Waldstreicher, Jonathan Reuben
    West Orange, NJ 07052 (US)
  • Krimskiy, William Sanford
    Bel Air, MD 21015 (US)
  • Schwartz, Yitzhack
    34606 Haifa (IL)
  • Shalgi, Avi
    Irvine, CA 92604 (US)
  • Bar-Tal, Meir
    3224009 Haifa (IL)
  • Amit, Matityahu
    44862 Zur-Yigal (IL)
  • Hayam, Gal
    36501 Tivon (IL)
  • Itah, Refael
    69630 Tel-Aviv (IL)
  • Ainsworth, Robert D.
    Scotts Valley, CA California 95066 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
WO-A2-2008/046031
US-A1- 2007 016 072
US-A1- 2010 041 949
 US-A1- 2002 165 448
US-A1- 2008 183 080
US-A1- 2010 198 192
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).